Skip to main content
OpenTrials

Clinical trial condition

Multiple Myeloma

Explore clinical trials studying Multiple Myeloma. Study availability and eligibility vary by location and protocol.

1,662 public trials 323 recruiting studies
Refine in advanced search Browse all conditions

Multiple Myeloma trial results

Completed

A Study of JNJ-54767414 (HuMax CD38) (Anti-CD38 Monoclonal Antibody) in Combination With Backbone Treatments for the Treatment of Patients With Multiple Myeloma

NCT01998971

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Duarte, California, United States
  • Atlanta, Georgia, United States
  • Chicago, Illinois, United States
  • Indianapolis, Indiana, United States
View all 22 locations
View Trial Details
Completed

Post Marketing Surveillance on Safety Evaluation of POMALYST® (Pomalidomide) Treatment of Multiple Myeloma in Korea

NCT03288974

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • Korea University Ansan Hospital Ansan, South Korea
  • Hallym University Sacred Heart Hospital Anyang, South Korea
  • Soonchunhyang University Hospital Bucheon-si, South Korea
  • Inje University Busan Paik Hospital Busan, South Korea
View all 33 locations
View Trial Details
Completed

A Study to Evaluate Daratumumab in Transplant Eligible Participants With Previously Untreated Multiple Myeloma

NCT02541383

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • BE-Antwerp-ZNA Stuivenberg Antwerp, Belgium
  • AZ St Jan Brugge Oostende AV Bruges, Belgium
  • Institut Jules Bordet Brussels, Belgium
  • UCL Saint-Luc Brussels, Belgium
View all 107 locations
View Trial Details
Completed

A Study of Real-life Current Standards of Care in Patients With Relapsed and/or Refractory Multiple Myeloma Who Received at Least 3 Prior Lines of Therapy Including Proteasome Inhibitor (PI), Immunomodulatory Drug (IMID), and Cluster of Differentiation 38 (CD38) Monoclonal Antibody Treatment

NCT04035226

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Oncology Institute of Hope and Innovation Glendale, California, United States
  • Marin Cancer Center Greenbrae, California, United States
  • Asclepes Research Weeki Wachee, Florida, United States
  • Oncology Hematology Assoc of Central Illinois, P.C. d.b.a. Illinois CancerCare, P.C. Peoria, Illinois, United States
View all 75 locations
View Trial Details
Completed

Treatment of Relapsed/Refractory Multiple Myeloma (rrMM) With Pomalidomide in Clinical Practice

NCT02555839

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • LKH Feldkirch, Intern E, Hämatologie Feldkirch, Austria
  • Medical University Graz Graz, Austria
  • KH der Elisabethinen Linz , 1. Interne Hämato-Onkologie Linz, Austria
  • Kepleruniversitätsklinikum GmbH, Hämatologie und Internistische Onkologie Linz, Austria
View all 13 locations
View Trial Details

Related conditions